Published in Am J Trop Med Hyg on July 01, 1962
FLUORESCENT ANTIBODY METHODS AND THEIR USE IN MALARIA RESEARCH. Bull World Health Organ (1964) 2.94
Influence of malaria infection on the elaboration of soluble mediators by adherent mononuclear cells. Infect Immun (1979) 1.27
Studies on antibody levels during vaccination of rhesus monkeys against Plasmodium knowlesi. Br Med J (1965) 1.09
A comparison of complement-fixation and fluorescent antibody methods in a longitudinal study of simian malaria infection. Bull World Health Organ (1967) 1.04
Studies on the relationship between fluorescent antibody response and ecology of malaria in Malaysia. Bull World Health Organ (1968) 0.88
The serology of malaria: recent applications. Bull N Y Acad Med (1969) 0.87
[Value of immunofluorescence during the detection and the epidemiologic study of human malaria]. Bull World Health Organ (1971) 0.85
A role for rheumatoid factor enhancement of Plasmodium falciparum schizont inhibition in vitro. Infect Immun (1984) 0.81
A NATURALLY ACQUITED QUOTIDIAN-TYPE MALARIA IN MAN TRANSFERABLE TO MONKEYS. Science (1965) 6.49
Fluorescent antibody staining of human malaria parasites. Exp Parasitol (1961) 3.33
A rapid flocculation test for the diagnosis of trichinosis. Public Health Rep (1951) 2.79
DRUG RESISTANCE IN PLASMODIUM FALCIPARUM FROM THAILAND. Am J Trop Med Hyg (1963) 2.42
MALARIAL ANTIBODY TITRES OF WEST AFRICANS IN BRITAIN. Br Med J (1963) 2.28
Fluorescence of tetracycline antibiotics in bone. J Bone Joint Surg Am (1958) 2.27
Vivax-type malaria parasite of macaques transmissible to man. Science (1960) 2.08
ALTERATIONS IN SERUM PROTEINS AND 19S ANTIBODY PRODUCTION DURING THE COURSE OF INDUCED MALARIAL INFECTIONS IN MAN. Am J Trop Med Hyg (1965) 1.83
Fluorescent antibody studies on cross reactions between human and simian malaria in normal volunteers. Am J Trop Med Hyg (1962) 1.82
Korean vivax malaria. I. Natural history and response to chloroquine. Am J Trop Med Hyg (1953) 1.75
Pitfalls in a discovery: the chronicle of chloroquine. Am J Trop Med Hyg (1963) 1.66
Korean vivax malaria. V. Cure of the infection by primaquine administered during long-term latency. Am J Trop Med Hyg (1953) 1.66
Bone localization of the tetracyclines. J Natl Cancer Inst (1957) 1.63
A possible mechanism of prolonged antimalarial activity. Am J Trop Med Hyg (1961) 1.53
Studies in human malaria. XXX. A summary of 204 sporozoite-induced infections with the Chesson strain of Plasmodium vivax. J Natl Malar Soc (1950) 1.52
[The influence of strain, sex and age of mice on infection with Plasmodium berghei]. J Infect Dis (1953) 1.49
Antibody production in human malaria as determined by the fluorescent antibody technique. Science (1962) 1.47
Reaction of human sera with mammalian chromosomes shown by fluorescent antibody technique. Science (1961) 1.47
Korean vivax malaria. II. Curative treatment with pamaquine and primaquine. Am J Trop Med Hyg (1953) 1.35
Certain technical aspects of fluorescence microscopy and the Coons fluorescent antibody technique. J Histochem Cytochem (1958) 1.33
Studies in human malaria. XXXIV. Acquired resistance to pyrimethamine (daraprim) by the Chesson strain of plasmodium vivax. Am J Trop Med Hyg (1953) 1.29
The in vitro activity of certain antimalarials against erythrocytic forms of Plasmodium gallinaceum. Am J Trop Med Hyg (1952) 1.27
Cure of Korean vivax malaria with pamaquine and primaquine. J Am Med Assoc (1952) 1.27
Studies in human malaria. XXXI. Comparison of primaquine, isopentaquine, SN-3883, and pamaquine as curative agents against Chesson strain vivax malaria. Am J Trop Med Hyg (1953) 1.26
QUARTAN-TYPE MALARIA PARASITE OF NEW WORLD MONKEYS TRANSMISSIBLE TO MAN. Science (1963) 1.26
The effect of malaria (Plasmodium berghei) on leukemia L1210 in mice. J Infect Dis (1954) 1.23
The influence of antimalarial drugs on nucleic acid synthesis in Plasmodium gallinaceum and Plasmodium berghei. Biochem Pharmacol (1961) 1.22
The efficiency of the zinc sulfate technic in the detection of intestinal protozoa by successive stool examinations. Am J Trop Med Hyg (1951) 1.20
THE EFFECT OF A REPOSITORY PREPARATION OF THE DIHYDROTRIAZINE METABOLITE OF CHLORGUANIDE, CI-501, AGAINST THE CHESSON STRAIN OF PLASMODIUM VIVAX IN MAN. Am J Trop Med Hyg (1963) 1.20
DRUG-RESISTANT FALCIPARUM MALARIA FROM CAMBODIA AND MALAYA. Trans R Soc Trop Med Hyg (1963) 1.15
Man to man transfer of two strains of Plasmodium cynomolgi by mosquito bite. Am J Trop Med Hyg (1962) 1.15
Studies on the compound 50-63. Trans R Soc Trop Med Hyg (1952) 1.04
Chloroquine or pyrimethamine in salt as a supressive against sporozoite-induced vivax malaria (Chesson strain). Bull World Health Organ (1958) 1.01
The use of antibiotics in the treatment of malaria. Ann N Y Acad Sci (1952) 0.97
Transmission of the M strain of Plasmodium cynomolgi to man. Am J Trop Med Hyg (1961) 0.94
Studies in human malaria. XXVI. Simultaneous infection with the Chesson and the St. Elizabeth strains of Plasmodium vivax. J Natl Malar Soc (1950) 0.93
Review of investigations in malaria chemotherapy; (U.S.A.) 1946 to 1954. Am J Trop Med Hyg (1955) 0.93
Experimental infection of the rabbit with Endamoeba histolytica. Am J Trop Med Hyg (1949) 0.93
Simian malaria. Its importance to worldwide eradication of malaria. JAMA (1963) 0.93
A microscopic study of tetracycline localization in skeletal neoplasms. J Histochem Cytochem (1961) 0.92
Differences in survival of several inbred strains of mice and their hybrids infected with Plasmodium berghei. J Infect Dis (1954) 0.91
CYCLOGUANIL PAMOATE (CI-501) AS A CAUSAL PROPHYLACTIC AGAINST A SOUTHERN RHODESIAN STRAIN OF FALCIPARUM MALARIA. Am J Trop Med Hyg (1964) 0.90
Human infection with a subcutaneous filarial worm. Am J Trop Med Hyg (1962) 0.90
DETECTION OF MALARIA ANTIBODIES--IMMUNODIAGNOSIS. Am J Trop Med Hyg (1964) 0.89
Alterations in haptoglobin levels. JAMA (1963) 0.88
Laboratory results on the efficacy of terramycin, aureomycin and bacitracin in the treatment of asymptomatic amebiasis. Am J Trop Med Hyg (1951) 0.86
Primaquine and quinocide as curative agents against sporozoite-induced Chesson strain vivax malaria. Bull World Health Organ (1962) 0.85
A further study of the toxicity of pyrimethamine (daraprim) in mna. Am J Trop Med Hyg (1953) 0.85
Effect of certain drugs on exoerythrocytic parasites of Plasmodium cynomolgi. Am J Trop Med Hyg (1962) 0.84
Studies in human malaria. XXV. Trial of febrifugine, an alkaloid obtained from Dichroa febrifuga lour., against the Chesson strain of Plasmodium vivax. J Natl Malar Soc (1950) 0.84
Studies in human malaria; the organization of a program for testing potential antimalarial drugs in prisoner volunteers. Am J Hyg (1948) 0.83
The chemotherapy of malaria in relation to our knowledge of exoerythrocytic forms. J Parasitol (1948) 0.83
Chemotherapy of malaria. Monogr Ser World Health Organ (1955) 0.82
Studies in human malaria. XXVIII. Observations on the use of chloroguanide against the Chesson strain of Plasmodium vivax. J Natl Malar Soc (1950) 0.82
Studies in human malaria; the protective and therapeutic action of chloroquine (SN 7618) against St. Elizabeth strain vivax malaria. Am J Hyg (1949) 0.81
FURTHER OBSERVATIONS ON THE ANTIMALARIAL ACTIVITY OF CI-501 (CAMOLAR) AGAINST THE CHESSON STRAIN OF VIVAX MALARIA. Am J Trop Med Hyg (1964) 0.81
Parasitological considerations relative to the diagnosis of amebiasis. Am J Gastroenterol (1955) 0.81
THERAPEUTIC TRIALS OF A DIHYDROXYNAPHTHALENE (377C54) AGAINST PLASMODIUMFALCIPARUM AND PLASMODIUM VIVAX INFECTIONS IN HUMAN VOLUNTEERS. Am J Trop Med Hyg (1963) 0.81
THE ANTIBODY RESPONSE IN VOLUNTEERS WITH CYNOMOLGI MALARIA INFECTIONS. Am J Trop Med Hyg (1964) 0.80
Survey of antimalarial agents: chemotherapy of Plasmodium gallinaceum infections; toxicity; correlation of structure and action. Public Health Monogr (1953) 0.80
EXPERIMENTAL ADAPTATION OF SIMIAN MALARIAS TO ABNORMAL HOSTS. J Parasitol (1963) 0.80
Differential neutrophil counts in pregnancy. N Engl J Med (1962) 0.80
Physiological disposition of pyrimethamine-H3. Exp Parasitol (1961) 0.79
Studies in human malaria; homologous strain superinfection during latency in subjects with sporozoite-induced vivax malaria (St. Elizabeth strain). Am J Hyg (1947) 0.79
Present concepts and treatment of plasmodium vivax malaria. AMA Arch Intern Med (1954) 0.78
Clinical and physiological responses in sporozoite-induced B strain Plasmodium cynomolgi and Plasmodium vivax infections in normal volunteers. Trans R Soc Trop Med Hyg (1962) 0.78
Chloroquine and chlorguanide as suppressants of malaria in Guatemala. Am J Trop Med Hyg (1953) 0.78
Studies in human malaria. XXVII. Observations on the use of pentaquine in the prevention and treatment of Chesson strain vivax malaria. J Natl Malar Soc (1950) 0.78
Malaria in man. Infection by Plasmodium vivax and the B strain of Plasmodium cynomolgi. JAMA (1963) 0.78
Studies on Plasmodium gallinaceum Brumpt; the incidence and course of the infection in young chicks following the subcutaneous inoculation of pooled sporozoites. Am J Hyg (1945) 0.77
The abnormal life span of the red blood cell. JAMA (1963) 0.77
Treatment of Strongyloides stercoralis infection with intravenous gentian violet. Am J Trop Med Hyg (1957) 0.77